Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
Boehringer Ingelheim
CHA University
Erasmus Medical Center
University Hospital, Montpellier
Huashan Hospital
Helse Nord-Trøndelag HF
University Hospital, Ghent
Ludwig-Maximilians - University of Munich
Assistance Publique - Hôpitaux de Paris
Karolinska University Hospital
University Hospital, Montpellier
Post Graduate Institute of Medical Education and Research, Chandigarh
Nanfang Hospital, Southern Medical University
Peking University People's Hospital
Istituto Clinico Humanitas
Istituto Clinico Humanitas
Fondazione del Piemonte per l'Oncologia
University of Roma La Sapienza
National Health Research Institutes, Taiwan